"The Mechanic" Cellular Energy Optimization Protocol

Your cells make energy the same way they always have. But the machinery doing it degrades over decades, and by the time most people notice something is wrong, the problem has been building for years.

Understanding why that happens requires a quick map of how energy actually gets made.

Everything starts with food. The glucose and fat you eat gets broken down and fed into something called the electron transport chain, which is a series of protein complexes embedded in the inner mitochondrial membrane. These complexes pass electrons down the chain like a relay race, and that movement pumps protons across the membrane, which drives an enzyme called ATP synthase to spin and produce ATP, the actual energy currency your cells spend. The whole system depends on the membrane holding its structure, the protein complexes being intact, and the electron carriers doing their job of shuttling between them.

Three things happen with age that break each part of that system.

The first is structural. The inner mitochondrial membrane is anchored by something called cardiolipin, which is a specialized phospholipid that physically holds the protein complexes in the right geometry. When cardiolipin gets damaged, the complexes drift apart, electrons start leaking out before they reach their destination, and that leakage produces something called reactive oxygen species, or ROS, which is essentially oxidative waste that damages the membrane further. The structure degrades, which causes more leakage, which causes more damage.

The second is chemical. Your cells use a molecule called NAD+ to accept electrons early in the process, and without enough of it, the whole chain slows down. A key drain on NAD+ is an enzyme called CD38, which breaks NAD+ down as a byproduct of immune activity. What makes this worse is that aging cells become something called senescent cells, which are cells that have stopped dividing but refuse to die, and they release inflammatory signals that cause macrophages to upregulate CD38. Research from 2020 confirmed this causal chain directly: senescent cells drive macrophage CD38 activity, and macrophage CD38 activity drives NAD+ decline. CD38 activity increases two to three fold with age, and mice that had CD38 knocked out maintained NAD+ levels across their lifespan in a way normal aging mice did not.

The third is mechanical. The electron transport chain relies on mobile carriers to shuttle electrons between the fixed complexes. The main one is something called CoQ10, or coenzyme Q10, which ferries electrons between Complex I and Complex III specifically. CoQ10 synthesis declines with age, and without enough of it, electron flow slows even when the structural components are intact.

So the repair logic follows directly from the damage pattern.

You start by stabilizing the membrane, because everything downstream depends on the structure holding. SS-31 is a compound that selectively binds cardiolipin on the inner mitochondrial membrane. It does not just sit there: it physically stabilizes the cristae geometry, which keeps the protein complexes in position, which reduces electron leakage, which reduces ROS. Research published in the Journal of the American Society of Nephrology showed that SS-31 re-energized ischemic mitochondria specifically through this cardiolipin interaction. The conservative dose range of 1 to 2 milligrams per day for four to eight weeks gives the membrane time to restabilize before layering anything else on top.

While the membrane is being addressed, the senescent cell burden gets addressed separately. FOXO4-DRI works by interrupting a survival signal inside senescent cells. Senescent cells resist apoptosis in part because a protein called FOXO4 sequesters p53, which is the protein that would normally trigger cell death. FOXO4-DRI displaces that interaction, freeing p53 to do its job. The research that validated this mechanism showed 11.73-fold selectivity for senescent cells over healthy cells, meaning the compound preferentially targets the problem population rather than indiscriminate cell death. The temporary feeling of being off during the three-dose course reflects the immune system clearing the dying cells, which is the expected and intended outcome.

Epithalon adds a third layer to the repair phase through a different mechanism entirely. This is a tetrapeptide that appears to act on telomerase, which is the enzyme responsible for maintaining telomere length in cells. The research confirmed that Epithalon induced expression of hTERT, the catalytic subunit of telomerase, and produced actual telomere elongation in human fibroblasts. The short course structure of 10 to 20 days, done once or twice per year, reflects how the compound is used rather than something taken continuously.

Once structural repair is underway, the optimization phase shifts the goal from stabilizing the machinery to driving its performance.

MOTS-c is a peptide derived from within the mitochondrial genome itself, which makes it unusual. It activates something called AMPK, which is a cellular energy sensor that responds to low energy states by reorganizing metabolism toward more efficient fuel use. The original research showed MOTS-c activates AMPK through inhibition of the folate cycle, and that this activation prevented insulin resistance and diet-induced obesity in animal models. At 5 to 15 milligrams per week split across three injections, you are pushing the now-repaired mitochondria to operate with better coordination rather than just hoping they function.

On NAD+ support specifically: the reason niacin is the recommended form rather than NMN or NR comes down to absorption. Research published in Science Advances in 2025 confirmed that most oral NMN and NR gets converted to niacin-pathway metabolites in the gut before it ever reaches systemic circulation anyway. You are paying significantly more for a conversion that the gut performs regardless. And exercise produces its own NAD+ effect through NAMPT, which is the rate-limiting enzyme in NAD+ synthesis: one study found NAMPT protein increased 127% in previously sedentary subjects after a training intervention, which is a larger effect than most supplemental approaches produce.

L-carnitine is a straightforward add-on because it performs a specific physical function: it is the only molecule that carries long-chain fatty acids across the inner mitochondrial membrane to be oxidized for fuel. Without sufficient carnitine, those fatty acids cannot enter the mitochondria regardless of how well the rest of the machinery functions.

The reason this protocol is sequenced the way it is rather than taken all at once is that you cannot meaningfully optimize a degraded system. Running MOTS-c through mitochondria with damaged cardiolipin and a high senescent cell burden is like pushing harder on an engine with a cracked block. The repair has to precede the optimization for the optimization to produce anything.

Your training, your sleep, and your nutrition are the underlying signal that tells the mitochondria what to build capacity for. This protocol improves the hardware. But the hardware still needs a reason to perform.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness